Feline Atopic Dermatitis Drug Market Insights Video
According to Cognitive Market Research, the global Feline Atopic Dermatitis Drug market size was USD 2864.5 million in 2024. It will expand at a compound annual growth rate (CAGR) of 16.00% from 2024 to 2031.
North America held the major market share for more than 40% of the global revenue with a market size of USD 1145.80 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.2% from 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 859.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.5% from 2024 to 2031.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 658.84 million in 2024 and will grow at a compound annual growth rate (CAGR) of 18.0% from 2024 to 2031.
Latin America had a market share of more than 5% of the global revenue with a market size of USD 143.23 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.4% from 2024 to 2031.
Middle East and Africa had a market share of around 2% of the global revenue and was estimated at a market size of USD 57.29 million in 2024 and will grow at a compound annual growth rate (CAGR) of 15.7% from 2024 to 2031.
The Corticosteroids held the highest Feline Atopic Dermatitis Drug market revenue share in 2024.
